Central Nervous System Diseases

Developing products to treat diseases of the central nervous system poses a number of hurdles.

Recruitment difficulties. Subjective outcome measures. Treatment adherence issues.

Axzons can help you navigate the challenges of any CNS study from Alzheimer’s trials to pain studies. So you can reduce costs, accelerate timelines and manage risk.

Axzons’s CNS experts and data-driven approach can help you overcome obstacles to your product’s success:
  • Clinical development – Our team leverages expertise in protocol design, biomarker strategies and diagnostic imaging technologies that are opening doors for CNS research
  • Trial operations – Global medical and operational staff accelerate recruitment and streamline trials
  • Outcomes reporting – Trained investigators understand the nuances of subjective outcomes
  • Commercial strategies – Sales and marketing specialists with neuroscience experience can speed your market entry

For your next CNS study, rely on our deep expertise in a wide range of psychological and neurological disorders:

  • ADHD, Bipolar disorders, Multiple Sclerosis, Sleep disorders
  • Addiction disorders, Depression, Pain Stroke
  • Alzheimer’s disease, Epilepsy, Parkinson’s disease
  • Anxiety, Migraine, Schizophrenia